WSFS Financial heads into next week's May 14 earnings call with the Street in a notably constructive mood — target prices rising across the board, short interest modest and retreating, and the borrow market wide open.
The most striking development this week is the unanimity of analyst upward revisions. Every firm that touched WSFS in the last ten days moved its target higher, none moved it lower. Piper Sandler raised its target to $80 from $72 on Wednesday, maintaining Neutral, while TD Cowen — the lone outright Buy in the group — lifted to $82 from $77 last week. DA Davidson and Stephens & Co. also nudged targets upward in late April. The consensus price target now sits at roughly $79.40, about 10.5% above the current $71.85. The split in ratings is instructive: most analysts remain Neutral or Market Perform, acknowledging the setup is decent but not cheap enough to swing outright bullish. Bulls point to the Delaware Valley franchise, consistent Wealth & Trust fee growth, and a strong capital return story; bears flag interest rate sensitivity and a valuation that already prices in much of the good news.
The EPS momentum picture supports the constructive tone. WSFS ranks in the 93rd percentile on 30-day EPS momentum and 87th on a 90-day basis — the company has been consistently beating estimates, and the factor score on EPS surprise lands in the 72nd percentile. The trailing P/E on a quarterly basis is elevated at roughly 11.3x on the snapshot's simpler ORTEX multiple (the fundamentals API flags a noisier LTM figure reflecting Q1 results). Price-to-book is 1.25x, up about 7% over the past month as the stock recovered 8.4% in April. Return on equity is running near 12.8% — respectable for a mid-cap regional bank but not a standout that commands a steep premium.
Short positioning is a non-story here, and intentionally so. Short interest has eased about 2% over the past week to roughly 2.9% of the free float — a level too low to generate meaningful squeeze dynamics in either direction. Borrowing costs are negligible at 0.50%, and the borrow market is loose, with availability far from stressed. The ORTEX short score of 35.7 is barely in the lower third of the universe, consistent with shorts treating this as a routine hedge rather than a conviction short. Nothing in the lending market suggests any building pressure.
Where there is any caution, it comes from a handful of insider sales on April 15. CEO Rodger Levenson sold just over 4,300 shares in two transactions, joined by the COO, CRO, and several EVPs — all on the same day, all at $69.07. These look routine in nature (the same-day, same-price pattern typically signals a scheduled equity programme rather than discretionary selling), and the trade significance scores are all rated 1 out of 10. Net of 90-day flows, insiders are actually slight net buyers on a share-count basis, though the pattern warrants a quick look. Cooke & Bieler cut their holding by 266,600 shares in Q1, one of the larger institutional moves in the ownership table, but the index-passive holders — BlackRock at 15.1%, Vanguard at 11.4% — remain anchored.
The May 14 print is the next clean read on whether NIM stability and loan growth can sustain the pace that had analysts raising targets in unison. The Q1 result (April 23-24 in the history data) produced a ~2.9% one-day gain and a five-day follow-through of about 3.7% — modest, positive reactions. What the next report needs to do is validate the forward EPS trajectory that underpins those freshly raised price targets.
See the live data behind this article on ORTEX.
Open WSFS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
